NCT01648231 - Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Amlodipine and Losartan in Health Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 6, 2012

Primary Completion Date

September 25, 2012

Study Completion Date

September 25, 2012

Conditions

Hypertension

Interventions

DRUG

Reference Treatment: 1 x 5mg amlodipine tablet and 1 x 100mg losartan tablet administered in fasted state

1 x 5mg amlodipine tablet and 1 x 100mg losartan tablet administered in fasted state

DRUG

Fixed Dose Combination 1: 1 x 5mg amlodipine / 100mg losartan tablet administered in fasted state

1 x 5mg amlodipine / 100mg losartan tablet administered in fasted state

DRUG

Fixed Dose Combination 2: 1 x 5mg amlodipine / 100mg losartan tablet administered in fasted state

1 x 5mg amlodipine / 100mg losartan tablet administered in fasted state

Trial Locations (1)

GSK Investigational Site, Randwick